ABACAVIR SULFATE AND LAMIVUDINE

ANDA

ABACAVIR SULFATE; LAMIVUDINE | A205412 | HETERO LABS LTD UNIT V

1 strength0 unique patents0 unique exclusivities

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Sep 29, 2014	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — EQ 600MG BASE;300MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Apr 16, 2025

No patent or exclusivity listings for this strength.